Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128658) titled 'A Multicenter, Randomized, Double-blind, Parallel-group Phase II Clinical Study Evaluating the Efficacy and Safety of SHR-1139 Injection in Patients with Moderate-to-severe Plaque Psoriasis' on July 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Dematology Hospital of Southern Medical University
Condition:
Moderate-to-severe Plaque Psoriasis
Intervention:
Group 2:Two doses of SHR-1139 injection and one dose of either SHR-1139 injection or placebo
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-07-27
Target Sample Size: Group 2:30;Group 1:30;
...